Compass Therapeutics (CMPX) Notes Payables (2018 - 2020)

Compass Therapeutics has reported Notes Payables for 3 years, with the latest figure at $103110.0 in Q1 2020.

• Quarterly Notes Payables rose 42.96% year-over-year to $103110.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $103110.0 (up 42.96% YoY) and the FY2020 annual result came in at $103110.0, up 42.96% from the prior year.
• Notes Payables slipped to $103110.0 in Q1 2020 per CMPX's latest filing, from $494000.0 in the prior quarter.
• Over five years, Notes Payables peaked at $494000.0 in Q4 2019 and troughed at $34525.0 in Q1 2018.
• A 3-year average of $113652.2 and a median of $72125.0 in 2019 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2019 and 2020: Notes Payables surged 695.17% in 2019, then surged 42.96% in 2020.
• Over 3 years, Notes Payables stood at $62125.0 in 2018, then soared by 695.17% to $494000.0 in 2019, then sank by 79.13% to $103110.0 in 2020.
• According to Business Quant data, Notes Payables over the past three periods registered $103110.0, $494000.0, and $85610.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.